Saudi Arabia’s Vision 2030 push into manufacturing, as well as the growing trend of Saudi nutraceuticals exports, exposes manufacturers to contrasting regulatory environments in global markets, which can lead to lengthy regulatory approvals, recalls or entire market denials. Managing this risk leads many Saudi producers with the help of nutraceutical formulation consultant to utilize bolded Global compliance benchmarking to identify their needs and map them against worldwide regulations and authorities. Such robust Regulatory compliance strategies lead to reduced time-to-market and predictable access to the GCC, EU, ASEAN, and US markets in the face of increased regulations slated for 2025-2026. [1] [2]
How Saudi Arabia Nutraceutical Companies Use Global Compliance Benchmarking to Meet Global Regulatory Standards
Saudi Arabia’s Vision 2030 push into manufacturing, as well as the growing trend of Saudi nutraceuticals exports, exposes manufacturers to contrasting regulatory environments in global markets, which can lead to lengthy regulatory approvals, recalls or entire market denials. Managing this risk leads many Saudi producers with the help of nutraceutical formulation consultant to utilize bolded Global compliance benchmarking to identify their needs and map them against worldwide regulations and authorities. Such robust Regulatory compliance strategies lead to reduced time-to-market and predictable access to the GCC, EU, ASEAN, and US markets in the face of increased regulations slated for 2025-2026. [1] [2]
Regulatory Landscape in Saudi Arabia in 2025-2026
The SFDA has updated their framework and provided clarification with regard to product classification (functional foods vs health product), alongside issuing guidelines like SFDA.FD 55 (Vitamin and Mineral Ranges) SFDA.FD 5013 (Novel foods and botanicals) SFDA.FD 2333 (Health/ nutrition claims) The food registration system (online portal) along with the introduction of electronic tracking system supports exporters. They have also come in alignment with the standard like ISO 22000 and Codex and GCC standards. SFDA.FD 55 (Vitamin and mineral range), SFDA.FD 5013 (novel foods/ botanical), SFDA.FD 2333 (health/ nutrition claims), and the digitalisation framework (food registration portal/electronic tracing) helps the products be export ready. The most recent changes to the Saudi Arabia regulatory framework for 2025-2026 place a great emphasis on substantiation for claims through scientific evidence, stability of botanicals, appropriate analytical methodologies and sustainability declarations, thus significantly increasing document submission and testing requirements for export. [3] [4]
What is Global Compliance Benchmarking?
Global Compliance Benchmarking is a method to map local regulations vs the regulatory standards of global regulatory authorities (FDA, EFSA, Codex, GCC) in advance and avoid approval issues before submitting it. The practical applications:
- Test if your vitamin or mineral levels match requirements in SFDA.FD55 (Saudi FDA) compared to EU maximum limits and the US Daily values
- Check if your label and product information matches EU Regulation 1169/2011 and the FDA’s 21CFR101. [5] [6]
- Ensure the botanical authenticity, active compound analysis and any contaminants are within EFSA or WHO guidelines.
- Guide dossier formatting for international acceptance (ICH eCTD where applicable)
- Check compliance requirements for Good Manufacturing Practices (GMPs) and traceability for each country.
In essence, global compliance benchmarking helps you create a “one dossier – many markets” approach using the boldness in regulatory benchmarking methods. [3] [7]
Why Saudi Nutraceutical Companies Are Increasing Benchmarking Activities?
Adoption because of overall increase in export figures, more stringent retailer demands, investor focus and regulatory complexity. Benchmarking can facilitate business regulatory compliance through improved label and claim accuracy, providing evidence of safety for innovative ingredients, and demonstrating traceability and ESG status. Through nutraceutical product development for startups, it can facilitate corporate governance compliance and credibility in the market. It can also de-risk bolded Compliance risk management through an early warning register for change (EFSA claim reviews, FDA ingredient notices) decrease the risk of recalls and regulatory failure and enhance approval and market access.
Key Benchmarking Areas for International Compliance
- Formulation & ingredient safety: Harmonize vitamin/ mineral levels, run for toxicology/stability of novel compounds.
- Labelling & claims: Use EFSA & FDA benchmark health/functional statements to steer clear of therapeutic claims.
- GMP, HACCP & ISO: Package production to the rules and standards of the international operational compliance standards and for the SFDA inspection readiness.
- Articles of botanical ingredients & contaminants: Verify identity, assay actives, screen heavy metals/pesticides/microbes.
- Traceability & supply chain: Batch level traceability, consider using blockchain if information needs to be immutable.
- Sustainable: Fulfil ESG and circular-economy requirements.
These used for regulatory benchmarking methods on actions that shall shorten time taken for cross border registration and eliminates redundancy in testing. [2]
Upcoming Regulatory Change Updates Affecting Saudi exporters 2025-2026
SFDA is increasing the bar on claim evidence; increasing surveillance on botanical & ingredient verification; implementing mandatory e-submission & increased tracing requirements; EU has increased scrutiny on claim registers & traceability; EU strengthened sustainability & packaging regulations. As result of this, it will create more challenges for dossiers, testing and labelling, making monitoring & Compliance assessment tools vital to ensure that submissions are not delayed.
Impact of Global Compliance Benchmarking on Nutraceuticals across Industries
Nutraceutical Product | Benchmarking Focus | Key Standards |
Vitamin limits and labelling | SFDA.FD 55; FDA 21 CFR 101; EU Reg 1924/2006 | |
Botanical Extracts | Identity and contaminant testing | SFDA.FD 5013; EFSA; WHO |
Functional Foods & Beverages | Claim substantiation | EU Reg 1924/2006; FDA |
Novel Ingredients | Toxicology and stability | SFDA.FD 5013; ICH |
Probiotics | Strain validation and safety | ISO 22000; FDA GMP |
Sports Nutrition | Protein verification and labels | Codex; ISO 22000 |
Immune Support Supplements | Traceability and shelf‑life | EU Traceability Regulation; FDA GMP |
Global Compliance Benchmarking supports all categories of aligning science, claim and safety requirements for different markets. Discover universal requirements and market nuances so that Saudi manufacturers save time, minimize repetitive testing and improve the efficiency of registration process crossing GCC, EU, ASEAN borders while ensuring strong supplements compliance. [4] [5] [6] [7]
Compliance Benchmarking Enabled by Technology
Many organizations now integrate AI-driven regulatory intelligence with Laboratory Information Management Systems (LIMS), Product Lifecycle Management (PLM), and Enterprise Resource Planning (ERP) platforms to maintain real-time compliance across multiple markets. Digital dossier managers and ERPs centralize document management, create auditable logs for regulatory audit practices and tracking. Blockchain allows trusted vendor validation and immutability of batch records. Innovative lab instruments improve predictivity of shelf-life studies and accelerate screen for potential contaminants. These are all solutions under the category of enterprise compliance solutions which allow to conduct regulatory benchmark scalable, scale up compliance readiness and to decrease the time and expense involved in achieving multi-market registrations. [2]
FRL Industry Insight & Case Study
Client challenge
A nutraceutical manufacturer in Saudi Arabian was having export rejections of their product due to substantiated claims and inaccurate labelling.
FRL approach
Conducted the compliance benchmarking solutions gap analysis against FDA/EFSA/GCC, revised formulations to adhere to SFDA.FD 55 limits, qualified the botanical ingredients & contaminants, and redrafted the dossier to ICH standards along with GMP audit readiness and traceability improvement by custom nutraceutical formulation solutions.
Results Obtained
SFDA approval of the product and achieve an improved dossier completeness by 40% with clearance to GCC and the EU. The solution incorporated regulatory compliance strategies, claim substantiation matrices, and supplier qualification steps.
Conclusion
Saudi nutraceutical companies require global compliance benchmarking for guaranteed reliable global market access. SFDA dossier alignment with global compliance, coupled with proactive compliance optimization strategies and technologies enables companies to minimize risk, fulfil retailer and investor requirements and ensure speedy exports and thus contributing towards Saudi’s Vision 2030 objectives for competitive global presence.
Work with Food Research Lab for the expertise on nutraceutical product development services for SFDA approval and international saleability for private label nutraceutical product development.
Frequently Asked Question
Benchmark your product against SFDA and target market regulations. Updating formulations, labels, and documentation before submission helps reduce compliance risks and approval delays.
Yes. Clinical studies or robust scientific evidence are generally required for health claims. Depending on the claim and target market, published scientific literature that meets SFDA, FDA, or EFSA requirements may also be acceptable.
Compliance benchmarking reduces duplicate testing, minimizes dossier revisions, lowers the risk of product rejection, and shortens regulatory approval timelines, helping companies save both time and development costs.
No. Blockchain is not mandatory, but it improves supply chain transparency, product traceability, and record integrity, making compliance easier for international markets and retailer requirements.
A cross-functional team including Regulatory Affairs, R&D, Quality Assurance, and Supply Chain should manage the process to ensure products meet both SFDA requirements and international regulatory standards.
References
- Patel, Nikunjana & Rangwala, Tasneem & Niyati, Acharya & Acharya, Sanjeev. (2025). Navigating the Maze of Regulatory Guidelines for Nutraceuticals in the Gulf Countries. 10.1201/9781003465041-16.
- Silpi, C. Nutraceuticals traditional practices, regulatory guidelines, opportunities and challenges. Discov Food5, 191 (2025). https://doi.org/10.1007/s44187-025-00437-z
- Alsager, S., Hashan, H. & Walker, S. The Saudi Food and Drug Authority: Shaping the Regulatory Environment in the Gulf Region. Pharm Med29, 93–103 (2015). https://doi.org/10.1007/s40290-015-0089-3
- GCC Board Directors Institute. (2024, May). Saudi Food & Drug Authority issues new and updated guidance documents – A Q1 & Q2 2024 update (KSA). GCC Board Directors Institute. https://gccbdi.org/legal-updates/saudi-food-drug-authority-issues-new-and-updated-guidance-documents-q1-q2-2024-update
- Saudi Food and Drug Authority. (n.d.). [Title of the specific news article]. Saudi Food and Drug Authority. https://www.sfda.gov.sa/en/news/5386609
- Office of the Federal Register, & National Archives and Records Administration. (2011). Code of Federal Regulations, Title 21, Part 101: Food labeling. U.S. Government Publishing Office. https://www.govinfo.gov/content/pkg/CFR-2011-title21-vol2/pdf/CFR-2011-title21-vol2-part101.pdf
- European Parliament, & Council of the European Union. (2006). Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods. Official Journal of the European Union, L 404, 9–25. https://eur-lex.europa.eu/eli/reg/2006/1924/oj/eng
Let’s create something Innovative and Delicious together
Food Research Lab strives for excellence in new Food, Beverage and Nutraceutical Product Research and Development by offering cutting edge scientific analysis and expertise.
